| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e0b9bc1c84e9332280944ae034c597b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9481780dd8b3f3cce037591e418b5c25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8413ac935f93708f0b8ab54b174891ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6fbb2cb7928dfd63c445fb1fea339114 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-40 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1037 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-10 |
| filingDate |
2009-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_379e830db5aa1a8941fa0c1316eb572b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e66121db7523df531d765caf65fe0148
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17b37f9947d71dc2da9c63f1c2ad6e3c |
| publicationDate |
2013-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8420051-B2 |
| titleOfInvention |
Muteins of hNGAL and related proteins with affinity for a given target |
| abstract |
The present invention relates to novel muteins derived from human lipocalin 2 (hNGAL) and related proteins that bind a given non-natural ligand with detectable affinity. The invention also relates to corresponding nucleic acid molecules encoding such a mutein and to a method for their generation. The invention further relates a method for producing such a mutein. Furthermore, the invention is directed to a pharmaceutical composition comprising such a lipocalin mutein as well as to various uses of the mutein. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013316962-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10865250-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9040020-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10618941-B2 |
| priorityDate |
2008-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |